Medicare Drug Plan Costs Set to Rise 50% in 2027
Medicare prescription drug premiums face a steep 50% hike in 2027, making open enrollment decisions critical for beneficiaries.
Medicare beneficiaries face a significant increase in prescription drug costs starting in 2027, with premiums projected to jump as much as 50%, according to a MarketWatch report. The sharp rise underscores the financial stakes for the tens of millions of Americans enrolled in Medicare Part D drug coverage.
The increase is expected to affect enrollees who remain passive during the annual open enrollment window, which runs each fall and allows beneficiaries to review, switch, or update their drug coverage plans. Financial advisers and consumer advocates warn that inaction during this period could leave seniors locked into plans that no longer offer competitive pricing or adequate coverage for their specific medications.
Read more Nvidia's Heavy Weight in 401(k) Plans Raises Index Risk Flags →
Open enrollment represents a critical opportunity for Medicare participants to compare plan options, assess formulary changes, and potentially avoid absorbing the full brunt of premium increases. Beneficiaries who actively shop their coverage each year are generally better positioned to find plans that balance cost and coverage needs.
The projected cost surge adds pressure to household budgets already strained by broader inflation, particularly for retirees on fixed incomes who depend on stable prescription drug expenses. Analysts note that the magnitude of the increase makes the upcoming enrollment season especially consequential compared to prior years.
Continue reading at MarketWatch.com